Washington Drug Letter

Oct. 1, 2012 | Vol. 44 No. 39

Depomed Suit: FDA Wrongfully Denied Orphan-Drug Exclusivity

Depomed is taking the FDA to court, claiming the agency violated federal laws and its own regulations when it denied the company’s orphan drug Gralise seven years of marketing exclusivity.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

KV Fighting: Asks Appeals Court to Review Makena Suit vs. FDA Endo to Court: Force FDA Opana Decision Before Impax Generics Come to Market Endo Asks Court to Force FDA Opana Decision Before Impax Generics Come to Market Cumberland Suit States FDA Wrongly Approved Acetadote Generic

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.